Impact For Patients: International Neonatal Consortium Impact For Patients: International Neonatal Consortium INC’s work has created a paradigm shift in clinical drug development for
Impact For Patients: Critical Path for Parkinson’s Consortium Impact For Patients: Critical Path for Parkinson’s Consortium CPP is leading the path to the use of remote monitoring technologi
Impact For Patients: Patient-Reported Outcome Consortium Impact For Patients: Patient-Reported Outcome Consortium Patient-Reported Outcome (PRO) Consortium helps to provide drug developer
Impact For Patients: TTC’s Work to Qualify a Reasonably Likely Surrogate Endpoint Impact For Patients: Transplant Therapeutics Consortium TTC’s work to qualify a reasonably likely surrogate endpoint will speed
Impact For Patients: TTC’s iBox Scoring System Impact For Patients: Transplant Therapeutics Consortium These stories highlight the value and impact that C-Path’s Transplant Th
Impact on Industry and Patients: Polycystic Kidney Disease Outcomes Consortium Impact on Industry and Patients: Polycystic Kidney Disease Outcomes Consortium C-Path as Convener, Curator, Innovator and Accelera
Impact on Industry: Critical Path to TB Drug Regimens Impact on Industry: Critical Path to TB Drug Regimens The collaborative work of the CPTR Initiative has contributed to the develop
Technological Break Throughs Lead to Improved T1D Outcomes, But Still Work to Be Done for T1DC Technological Break Throughs Lead to Improved T1D Outcomes, But Still Work to Be Done for T1DC By Alexander Diegel As a person liv
The Impact of C-Path’s Quantitative Medicine Program: Generating Cutting-edge Solutions to Accelerate Drug Development The Impact of C-Path’s Quantitative Medicine Program: Generating Cutting-edge Solutions to Accelerate Drug Development As a
